AzTrials
AzTrials

Postoperative AnalgesiaIPACKNCT07258277

Adductor Canal Block With IPACK Versus Genicular Nerves Block With IPACK for Post-operative Analgesia

A study testing IPACK with adductor canal block, IPACK with Genicular nerves block and Spinal Block in people with Postoperative Analgesia, run by Minia University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

In our study, we will find out the efficacy of those peripheral nerve blocks on postoperative pain in knee arthroscopy. The aim is to evaluate the efficacy of combined ultrasound-guided IPACK with adductor canal nerve block versus ultrasound-guided IPACK with genicular nerves block on postoperative pain in knee… Read more about this study

Who is it for?
Ages 20 to 70 years
Conditions the study is for
Postoperative Analgesia
What is being tested?
IPACK with adductor canal block, IPACK with Genicular nerves block and Spinal Block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteEgypt
Study dates
Dec 2025to Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA l \& ll
  • planned to undergo elective unilateral knee surgeries under spinal anesthesia
  • age between 20 to 70 years old
  • both sex

Who cannot join

  • Patient refusal
  • Neurological deficiencies prior to surgery
  • Severe Cardiovascular, renal and hepatic comorbidities
  • Hematological disorders and abnormal coagulation parameters
  • Psychiatric illnesses and opioid addiction
  • Allergies to any of the medications will be utilized in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Gehad F Sadek, MD of anesthesiology and ICU contact

0862344787 ext. 201061967724

gehad.fathy@minia.edu.eg

Abdelrahman Seif Amih, MBBCH contact

abdelrahmansaif480@gmail.com

Egypt1 site
  • Minia University Hospital

    Minya, Minya Governorate

    Hassan Mokhtar Elshourbagy, MD, 0862369076, hassan.hetta@mu.edu.eg

    Gehad Fathy Sadek, MD

Other trials in Egypt

About this study

Official title: Comparative Study Between Adductor Canal Block With IPACK (Infiltration Between the Popliteal Artery and Capsule of the Knee) Versus Genicular Nerves Block With IPACK for Post-operative Analgesia in Knee Arthroscopy

In our study, we will find out the efficacy of those peripheral nerve blocks on postoperative pain in knee arthroscopy.

The aim is to evaluate the efficacy of combined ultrasound-guided IPACK with adductor canal nerve block versus ultrasound-guided IPACK with genicular nerves block on postoperative pain in knee arthroscopy.

Read the detailed description

Effective perioperative pain treatment has been documented to facilitate accelerated rehabilitation and recuperation, hence providing improved functional outcomes among individuals following knee surgeries. As a result, there has been a need to create multimodal analgesic regimens that include the usage of both regional anesthetic and systemic analgesics (Society, 2012).

Management of pain for knee surgery has been challenging, where various methods like epidural, peripheral nerve block (PNB), Local Infiltration Analgesia (LIA), intravenous (IV) analgesics like opioids, non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular (IA) injections, have been used (Tian et al., 2020).

In knee surgeries, the most difficult factor to control is pain, but early movement following surgery can be facilitated by motor-sparing regional anesthetic blocks and ultrasound-guided nerve blocks (Leung et al., 2018).

Perioperative multimodal analgesic strategies, consisting of "motor-sparing" regional anesthetic techniques combined with systemic nonopioid medications that target various pain pathways, have been developed to mitigate this risk; they confer improved pain scores and patient satisfaction, reduced opioid consumption and opiate-related adverse effects, early postoperative ambulation, shortened hospital stay, and fewer surgical complications (Kandarian et al., 2019).

The adductor canal block (ACB) is a regional anesthesia technique used to provide analgesia to the anterior and medial areas of the thigh and the knee (El-Boghdadly et al., 2021).

The ACB targets the nerves that pass through the adductor canal. The primary nerve target of the ACB is the saphenous nerve, a branch of the femoral nerve. The saphenous nerve is responsible for the sensitive innervation of the leg's medial section, from the knee to the ankle. In addition to the saphenous nerve, the ACB may also block the anterior branches of the obturator nerve and the medial femoral cutaneous nerve, which supply sensation to the medial section of the thigh (Woodworth et al.,2023).

Often, it is challenging to adequately anesthetize the posterior knee through regional technique for postoperative analgesia. Local anesthetic infiltration of the interspace between the popliteal artery and capsule of the posterior knee, known as the IPACK block, can be used to reduce pain after knee surgery. The IPACK block is a novel regional technique developed to provide analgesia to this area without compromising motor function (Elliott \& Thobhani, 2014).

The IPACK, combined with ACB, involves blocking the sensory nerves of the anterior, medial, and posterior knee, preserving motor function to encourage early ambulation and expedited rehabilitation (Sankineani et al., 2018).

The genicular nerves include branches from the femoral, common peroneal, saphenous, tibial, and obturator nerves which innervate the knee capsule (Kim et al., 2018).

The superolateral, superomedial, and inferomedial branches of the genicular nerve were reported to be in proximity to the periosteum of tibia and femur, and the superolateral, inferolateral, superomedial, and inferomedial quadrants of the anterior knee joint were shown to be innervated by superior lateral, inferior lateral, superior medial and inferior medial branches of the genicular nerve, respectively alongside the branches of peroneal and femoral nerves (Tran et al., 2018).

A genicular nerve block specifically targets these branches for postoperative analgesia in knee surgery.

First analgesic request (to evaluate the efficacy of combined ultrasound-guided IPACK with adductor canal nerve block versus ultrasound-guided IPACK with genicular nerves block on postoperative pain in knee arthroscopy) is the primary outcome of the study.

VAS score (dynamic and static), Hemodynamics (heart rate, blood pressure and SpO2), Total analgesic requirements, Time Up and Go test (for calculating time of postoperative movement) and Complications as (Nausea, vomiting, Allergy, Tachycardia, Hypotension or Local anesthetic toxicity) are the secondery outcomes.

Neurological deficiencies prior to surgery, Severe Cardiovascular, renal, hepatic comorbidities, Hematological disorders, abnormal coagulation parameters, Psychiatric illnesses, opioid addiction or Allergies to any of the medications will be utilized in the study will be excluded.

A prospective randomized controlled clinical study will be conducted in anesthesiology and intensive care department at Minia University Hospital (MUH) on 72 adult patients of both genders, aged between 20 years to 70 years old, ǀ and ǀǀ classification of The American Society of Anesthesiologists (ASA) planned to undergo elective unilateral knee surgeries under spinal anesthesia.

Patients will be divided into 3 groups, each group includes 24 patients:

Being tested
IPACK with adductor canal block, IPACK with Genicular nerves block, Spinal Block
Keywords
IPACKL/ adductor canal block/ genicular nerves block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IPACK with adductor canal blockOther

    receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then another 15 ml of 0.25% plain bupivacaine at the mid-thigh for the ACB.

  • IPACK with Genicular nerves blockOther

    receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then at the anterior surface of the knee 16 ml of 0.25% plain bupivacaine divided on the 4 genicular nerves (superior medial, superior lateral, inferior medial and inferior lateral).

  • Spinal BlockOther

    won't receive any nerve block, only spinal anesthesia.

    • Then spinal anesthesia will be given to all patients in the three groups, 3 ml (15 mg) 0.5% hyperbaric bupivacaine will be administered intrathecal at level of L3-4 or L4-5 interspace.
Study groups in NCT07258277
Study groupRoleWhat they receive
IA (IPACK with adductor cannal block)Active comparatorreceive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then another 15 ml of 0.25% plain bupivacaine at the mid-thigh for the ACB.
Receives: Other: IPACK with adductor canal block
IG (IPACK with genicular nerves block)Active comparatorreceive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then at the anterior surface of the knee 16 ml of 0.25% plain bupivacaine divided on the 4 genicular nerves (superior medial, superior lateral, inferior medial and inferior lateral).
Receives: Other: IPACK with Genicular nerves block
C (Spinal block)Active comparatorwon't receive any nerve block, only spinal anesthesia. - Then spinal anesthesia will be given to all patients in the three groups, 3 ml (15 mg) 0.5% hyperbaric bupivacaine will be administered intrathecal at level of L3-4 or L4-5 interspace.
Receives: Other: Spinal Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. first analgesic request

    the first time the patient will ask analgesia postoperative

    Measured: within 24 hours

Secondary outcomes (3)
  1. Changes in Visual Analogue Score

    measuring pain intensity on a ruler with a score ranging from 0-100 mm (Weigl \& Forstner, 2021).

    • Dynamic: during the movement of the patient
    • Static: while the patient is bed ridden.
    • No pain: 0-4 mm
    • Mild pain: 5-44 mm
    • Moderate pain: 45-74 mm
    • Severe pain: 75-100 mm,

    Measured: To be measured immediately postoperative, 2h later, 4h, 6h, 8h, 12h, 18h, 24h

  2. Total analgesic requirement

    dose of fentanyl or paracetamol will be used postoperative

    Measured: within 24 hours

  3. Time Up and Go Test (TUG)

    • Ask the patient to get up from a chair
    • Then walk three meters, turn and return back to the chair
    • Finally, sit on the chair again
    • We calculate the time spent during the movements of the patient

    Measured: postoperative: 6h, 12h, 18h and 24h.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2025
  2. Study startDec 2025 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This prospective randomized controlled clinical study will be conducted in anesthesiology and intensive care department at Minia University Hospital (MUH) on 72 adult patients of both genders, aged between 20 years to 70 years old, ǀ and ǀǀ classification of The American Society of Anesthesiologists (ASA) planned to undergo elective unilateral knee surgeries under spinal anesthesia.Our 72 patients were randomly divided into 3 groups, each group includes 24 patients
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07258277
Sponsor's protocol ID
1391
Acronym
IPACK
Status last verified
Oct 2025
First submitted
20 Nov 2025
Last updated
2 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing IPACK with adductor canal block, IPACK with Genicular nerves block and Spinal Block in people with Postoperative Analgesia, run by Minia University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gehad F Sadek, MD of anesthesiology and ICU (0862344787 ext. 201061967724, gehad.fathy@minia.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

first analgesic request (time frame: within 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in